» Articles » PMID: 39055058

Association Between Telomere Length and Erectile Dysfunction: a Cross-sectional Study

Overview
Specialty Endocrinology
Date 2024 Jul 26
PMID 39055058
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Leukocyte telomere length (LTL) serves as a significant biomarker of aging. Erectile dysfunction (ED) is a commonly observed condition among middle-aged and older men. The objective of this study is to explore the potential association between LTL and ED.

Methods: We utilized data from the National Health and Nutrition Examination Survey (NHANES) to examine the association between LTL and ED. Weighted multivariate regression analyses were performed as the primary statistical method. Subgroup analyses were conducted to investigate specific population subsets, and restricted cubic spline (RCS) analyses were employed to assess the non-linear relationship between LTL and ED.

Results: The results of weighted multivariate regression analyses revealed a negative correlation between LTL and the risk of ED. Individuals with ED exhibited shorter LTL compared to those without ED. For each unit increase in LTL, there was a 54% reduction in the risk of ED (odds ratios[OR] 0.46, 95% confidence intervals[CI] 0.25-0.85). When LTL was considered as a categorical variable, the group with the longest LTL (Q5) had a 44% lower risk of ED compared to the group with the shortest LTL(Q1) (OR 0.56, 95% CI 0.39-0.81). A non-linear relationship was observed between TL and ED. Various sensitivity analyses were conducted to validate the stability of the results, and consistent findings were obtained.

Conclusion: The negative association between leukocyte LTL and ED suggests that delaying the shortening of LTL may decrease the risk of ED.

References
1.
Welendorf C, Nicoletti C, Augusta de Souza Pinhel M, Noronha N, Paula B, Nonino C . Obesity, weight loss, and influence on telomere length: New insights for personalized nutrition. Nutrition. 2019; 66:115-121. DOI: 10.1016/j.nut.2019.05.002. View

2.
Guo X, Li J, Qi Y, Chen J, Jiang M, Zhu L . Telomere length and micronuclei trajectories in APP/PS1 mouse model of Alzheimer's disease: Correlating with cognitive impairment and brain amyloidosis in a sexually dimorphic manner. Aging Cell. 2024; 23(5):e14121. PMC: 11113262. DOI: 10.1111/acel.14121. View

3.
Tamura Y, Takubo K, Aida J, Araki A, Ito H . Telomere attrition and diabetes mellitus. Geriatr Gerontol Int. 2016; 16 Suppl 1:66-74. DOI: 10.1111/ggi.12738. View

4.
Savage S . Telomere length and cancer risk: finding Goldilocks. Biogerontology. 2023; 25(2):265-278. DOI: 10.1007/s10522-023-10080-9. View

5.
Cawthon R . Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002; 30(10):e47. PMC: 115301. DOI: 10.1093/nar/30.10.e47. View